In contrast to FMR1 loss-of-function in FXS, a slight increase of FMR1 mRNA levels has been detected in FXTAS lymphoblastoid cells, supporting an RNA gain-of-function leading to the disease [113]. This evidence concerns the gene FMR1 and fragile X syndrome.